FTC Blesses GTCR's $675M Purchase Of Sterigenics

Law360, New York (March 8, 2011, 3:40 PM EST) -- The Federal Trade Commission on Tuesday granted an early termination of its antitrust review of Chicago private equity firm GTCR LLC's plan to buy Silverfleet Capital's medical device and pharmaceuticals sterilization company Sterigenics International Inc. for $675 million.

The FTC said it had accepted the companies' request for an early termination, meaning the agency has completed its antitrust review of the deal and decided not to take any enforcement action during the deal's statutory waiting period.

With no public shareholders in the picture, the FTC's move likely...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.